EP 1667712 A2 20060614 - B. PERTUSSIS ANTIGENS AND USE THEREOF IN VACCINATION
Title (en)
B. PERTUSSIS ANTIGENS AND USE THEREOF IN VACCINATION
Title (de)
B. PERTUSSIS ANTIGENE UND IHRE VERWENDUNG BEI DER VAKZINIERUNG
Title (fr)
ANTIGENES DE B. PERTUSSIS ET LEUR UTILISATION DANS LA VACCINATION
Publication
Application
Priority
- EP 2004011082 W 20041001
- GB 0323113 A 20031002
- GB 0323112 A 20031002
Abstract (en)
[origin: WO2005032584A2] The invention provides BASB232 polypeptides and polynucleotides encoding BASB232 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses. The invention further provides immunogenic compositions comprising a plurality of antigens selected from at least two different categories of antigen, having different functions within Bordetella. Examples of such categories of antigen are autotransporter proteins, iron acquisition proteins, lipoproteins, adhesins and toxins/invasins.
IPC 1-7
IPC 8 full level
A61K 39/10 (2006.01)
CPC (source: EP US)
A61K 39/099 (2013.01 - EP US); Y02A 50/30 (2017.12 - EP US)
Citation (search report)
See references of WO 2005032584A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005032584 A2 20050414; WO 2005032584 A3 20051110; AT E474595 T1 20100815; AU 2004277342 A1 20050414; AU 2004277342 B2 20101216; CA 2539715 A1 20050414; CA 2539715 C 20150224; DE 602004028262 D1 20100902; EP 1667712 A2 20060614; EP 1667712 B1 20100721; ES 2346314 T3 20101014; US 2007116711 A1 20070524; US 8574596 B2 20131105
DOCDB simple family (application)
EP 2004011082 W 20041001; AT 04765806 T 20041001; AU 2004277342 A 20041001; CA 2539715 A 20041001; DE 602004028262 T 20041001; EP 04765806 A 20041001; ES 04765806 T 20041001; US 57429704 A 20041001